Will the World Health Organisation deregulate Cannabis and what will this mean for CBD?

Will the World Health Organisation deregulate Cannabis and what will this mean for CBD?

The World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) released a report on Cannabis extract showing evidence that not only is it safe but highlighting that it isn’t addictive. The report also highlights that no public health problems, like driving under the influence have been associated with Cannabis extract. “In humans, Cannabidiol exhibits no effects indicative of any abuse or dependence potential,” wrote the World Health Organization, a U.N. agency that focuses on public health. 
An open letter from the WHO to the UN has been published advising that they consider deregulating Cannabis, including Hemp which UK CBD is made from, when they meet in March of this year as this article states from Forbes Magazine:
 

But how will this impact on CBD?

It is very challenging to keep up with the ever changing regulation around the sale of CBD and cannabis products. However we hope this information collected by meetharmony.com will help make things clearer.

The World Health Organisation just released a number of suggested developments and these are outlined below in relation to CBD and Cannabis

“Deleting” Cannabis from Schedule IV 

The World Health Organisation Expert Committee on Drug Dependence (ECDD) finally released their recommendations on cannabis. The UN Commission on Narcotic Drugs (CND) expected to pass new scheduling on cannabis in early March 2019 but has been waiting on the WHO’s formal recommendations.

The report recommends cannabis and cannabis resin “be deleted from Schedule IV of the Single Convention on Narcotics Drugs (1961).” This moves cannabis to Schedule I—significantly freeing access, research, and development.  

Pure CBD “Not Included” in Any International Drug Convention

The ECDD recommends that all pure CBD and CBD products containing under 0.2% THC would not be included in any international drug control conventions.

Because “cannabidiol found in cannabis and cannabis resin does not have psychoactive properties and has no potential for abuse and no potential to produce dependence.” 

3. Significantly Simplifying Cannabis

THC in all forms would be removed from the 1971 Convention and placed with cannabis in Schedule I of the 1961 Convention. Grouping all forms of THC in the same category as cannabis and cannabis resin makes classifying cannabis tremendously simpler.

The ECDD said two important things that make this possible:

  • The dangers associated with THC are similar to those of cannabis and cannabis resin, so having them all together in the same category is a matter of consistency.

  • Grouping all THC isomers makes sense when they are difficult to differentiate from each other through standard analysis.

The report provides an example of this disintegration of distinctions in its recommendation to delete extracts and tinctures of cannabis from Schedule I of the Single Convention on Narcotics Drugs (1961).

We hope this makes things a little clearer.

Thank you for reading our blog and if you are interested in trying any of our products please use the code CB10 for a 10% discount on your first order at checkout.

 


Leave a comment

x